Modular Medical, Inc. (MODD)
NASDAQ: MODD · Real-Time Price · USD
4.310
-0.040 (-0.92%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Modular Medical Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Selling, General & Admin | 6.79 | 4.35 | 4.65 | 4.82 | 7.2 | 3.25 | |
| Research & Development | 20.07 | 14.7 | 12.88 | 9.06 | 7.73 | 4.08 | |
| Operating Expenses | 26.86 | 19.05 | 17.53 | 13.88 | 14.93 | 7.34 | |
| Operating Income | -26.86 | -19.05 | -17.53 | -13.88 | -14.93 | -7.34 | |
| Interest Expense | - | - | - | - | -2.75 | -0.04 | |
| Other Non Operating Income (Expenses) | 0.08 | 0.23 | 0.06 | 0 | 0.37 | 0 | |
| EBT Excluding Unusual Items | -26.78 | -18.82 | -17.47 | -13.88 | -17.31 | -7.38 | |
| Other Unusual Items | - | - | - | - | -1.32 | - | |
| Pretax Income | -26.78 | -18.82 | -17.47 | -13.88 | -18.63 | -7.38 | |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | |
| Net Income | -26.78 | -18.82 | -17.47 | -13.88 | -18.63 | -7.38 | |
| Net Income to Common | -26.78 | -18.82 | -17.47 | -13.88 | -18.63 | -7.38 | |
| Shares Outstanding (Basic) | 2 | 1 | 1 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 2 | 1 | 1 | 0 | 0 | 0 | |
| Shares Change (YoY) | 63.25% | 65.38% | 84.89% | 77.78% | 9.60% | 4.31% | |
| EPS (Basic) | -14.75 | -15.26 | -23.42 | -34.40 | -82.11 | -35.63 | |
| EPS (Diluted) | -14.75 | -15.26 | -23.42 | -34.40 | -82.11 | -35.63 | |
| Free Cash Flow | -26.12 | -18.21 | -15.65 | -12.65 | -10.31 | -6.02 | |
| Free Cash Flow Per Share | -14.39 | -14.77 | -20.98 | -31.35 | -45.45 | -29.07 | |
| EBITDA | -25.3 | -17.99 | -17.1 | -13.73 | -14.81 | -7.23 | |
| D&A For EBITDA | 1.56 | 1.06 | 0.43 | 0.15 | 0.12 | 0.11 | |
| EBIT | -26.86 | -19.05 | -17.53 | -13.88 | -14.93 | -7.34 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.